DANIELLE BECKETT-SHEDD: Open Payments
NPI 1972015519 · COLDWATER, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$824 in 39 payments from 18 companies in 2025. Trend: 2023 $999 · 2024 $1,215 · 2025 $824
Food & beverage: $824
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 4 | $115 |
| Novo Nordisk Inc | 5 | $108 |
| Corcept Therapeutics | 4 | $97 |
| ABBVIE INC. | 5 | $93 |
| Axsome Therapeutics, Inc. | 3 | $64 |
| Dexcom, Inc. | 2 | $49 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| PFIZER INC. | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
Products named: FANAPT, Korlym, Ozempic, Auvelity, Dexcom G6 Transmitter, REXULTI, VRAYLAR, CAPLYTA.
Industry payments across MI — which companies pay providers there.
